Publication:
Use of recombinant factor VIIa in a preterm infant with coagulopathy and subdural hematoma

Simple item page
dc.contributor.authorBİLGEN, HÜLYA SELVA
dc.contributor.authorsAltuncu, Emel; Berrak, Su; Bilgen, Huelyya; Yurdakul, Ziya; Canpolat, Cengiz; Oezek, Eren
dc.date.accessioned2022-03-12T17:32:17Z
dc.date.accessioned2026-01-10T19:41:59Z
dc.date.available2022-03-12T17:32:17Z
dc.date.issued2007
dc.description.abstractActivated recombinant factor VIIa was administered to a preterm infant with bleeding diasthesis and a huge subdural hematoma that could not be controlled by the blood products. The coagulation tests were normalized the following day. Recombinant factor VIIa can be a choice in selected cases with intractable bleedings unesponsive to conventional replacement therapy.
dc.identifier.doi10.1080/14767050701411935
dc.identifier.issn1476-7058
dc.identifier.pubmed17674281
dc.identifier.urihttps://hdl.handle.net/11424/228531
dc.identifier.wosWOS:000248889200008
dc.language.isoeng
dc.publisherTAYLOR & FRANCIS LTD
dc.relation.ispartofJOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectfactor VIIa
dc.subjectpreterm
dc.subjectbleeding diasthesis
dc.subjectACTIVATED FACTOR-VII
dc.subjectHEMORRHAGE
dc.subjectPHARMACOKINETICS
dc.subjectMANAGEMENT
dc.subjectSURGERY
dc.subjectRFVIIA
dc.titleUse of recombinant factor VIIa in a preterm infant with coagulopathy and subdural hematoma
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage629
oaire.citation.issue8
oaire.citation.startPage627
oaire.citation.titleJOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
oaire.citation.volume20

Files

Collections

Araştırma Çıktıları